The characterization of the mechanisms responsible for regulation of the IGF1 pathway by p53, as described above, led us to formulate an hypothesis aimed at offering a generalized paradigm for regulation of IGF1R expression by different tumor suppressors (69, 113, 118). The gene discussed is IGF1R; the disease is neoplasm.